Full-Time

Clinical Sales Executive

Infusion

Deadline 6/11/27
BrightSpring Health Services

BrightSpring Health Services

10,001+ employees

Home-based and community health services, pharmacy

Compensation Overview

$90k - $105k/yr

Greensboro, NC, USA

In Person

Category
Sales & Account Management
Required Skills
Sales

Get referred to BrightSpring Health Services

Find people who can refer or advise you

Requirements
  • Must be a licensed Registered Nurse (RN) in the state of North Carolina.
  • Current nursing license in assigned state required.
  • Active RN license in assigned state.
  • Valid driver’s license and auto insurance required.
  • Must meet company driving standards.
  • Percentage of Travel: 0-25%.
  • Physical requirements include frequently sitting, and typing on a keyboard with fingers, and occasionally standing, walking, bending, reaching, climbing (stairs/ladders), kneeling, crouching and stooping; the ability to push/pull and lift/carry 1-10 lbs.
Responsibilities
  • Proactively build and maintain strong relationships with hospital referral sources including case managers, discharge planners, physicians, and care teams.
  • Serve as a key Amerita representative providing education, clinical consultation, and service support to referral partners.
  • Partner with Strategic Account Executives to execute territory growth strategies and achieve referral and admission goals.
  • Participate in joint sales calls, account planning, and growth initiatives to expand referral opportunities.
  • Conduct in-services, clinical education sessions, and CEU programs to promote awareness and appropriate utilization of Amerita services.
  • Communicate frequently with Account Executives to identify opportunities, assess progress, and support account development strategies.
  • Conduct bedside patient assessments to determine appropriateness for home or alternate-site infusion therapy.
  • Educate patients, caregivers, and facility staff using consultative sales techniques to explain therapy, services, and expectations for home care.
  • Provide hands-on patient and caregiver education to promote therapy independence and timely discharge.
  • Review patient medical records to obtain clinical history and insurance information necessary for admission processing.
  • Collect, review, and complete pre-admission documentation and coordinate required approvals.
  • Facilitate therapy start readiness through coordination of orders, documentation, and communication with intake and pharmacy teams.
  • Serve as the central clinical liaison coordinating communication between referral sources, intake, pharmacy, nursing, and operations teams.
  • Proactively initiate transition planning to ensure seamless movement of patients from hospital to home or alternate site of care.
  • Communicate patient readiness, clinical needs, and discharge timelines to internal teams to support timely start of care.
  • Coordinate required medical supplies, equipment, and therapy resources to support safe discharge.
  • Provide clinical input and oversight to ensure appropriate patient assessment and treatment planning.
  • Act as a consistent point of contact among providers, patients, and internal teams throughout the transition process.
  • Meet or exceed defined performance goals related to referrals supported, admissions, patient education activities, and therapy starts.
  • Maintain accurate and timely documentation of patient interactions, education sessions, and transition activities.
  • Participate in required patient tracking, therapy start monitoring, and reporting processes.
  • Maintain confidentiality of patient and proprietary information in accordance with HIPAA and company standards.
  • Adhere to all Amerita policies, regulatory requirements, accreditation standards, and clinical safety guidelines.
  • Demonstrate professional collaboration and customer-focused service with patients, referral partners, and internal teams.
Desired Qualifications
  • BSN (Bachelor of Science in Nursing) preferred.
  • Previous healthcare sales, clinical liaison, or business development experience preferred.
  • Experience working within hospital discharge planning or case management environments highly desirable.
  • Salesforce CRM experience preferred.
  • Proficiency in Microsoft Office Suite.
  • Strong organizational, problem-solving, and collaboration skills are desirable.
BrightSpring Health Services

BrightSpring Health Services

View

BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.

Company Size

10,001+

Company Stage

Post IPO Equity

Headquarters

Louisville, Kentucky

Founded

1974

Get referred to BrightSpring Health Services

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • 15–20% annual organic EBITDA growth targets through 2028 backed by AI efficiency and $2 billion acquisition capacity.
  • Overseas home health census grew 52% to 46,066 daily, fueling $442 million Provider Services revenue and market share gains.
  • Full-year revenue guidance raised to $14.98 billion midpoint, with EBITDA of $810 million exceeding analyst estimates of $779.5 million.

What critics are saying

  • Inflation Reduction Act caps will cut specialty pharmacy margins by 8–12%, eroding $2.64 billion infusion revenue in 2026–2027.
  • Amedisys-LHC integration failures will cause $15–25 million overruns and delay $30 million EBITDA by 9–12 months due to staffing gaps.
  • UnitedHealth-backed competitors will capture 15–20% of home health census by 2027, squeezing $442 million Provider Services revenue.

What makes BrightSpring Health Services unique

  • Integrated home and community care model combines pharmacy, home health, and behavioral services for complex chronic populations.
  • Exclusive ultra-narrow drug portfolio of 153 drugs drives 36% growth in specialty and infusion revenue to $2.64 billion.
  • AI-driven automation cuts IT resolution time by 96%, freeing clinical staff for high-value patient care across 50 US states.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-10%

1 year growth

-10%

2 year growth

-10%
Yahoo Finance
Apr 10th, 2026
BrightSpring Health shares jump 5.2% on 15-20% EBITDA growth targets and AI efficiency plans

BrightSpring Health Services announced the resignation of Robert Barnes as President of ResCare Community Living on 30 March 2026, stating it was not due to any disagreement over operations or policies. The company's shares rose 5.2% following upbeat analyst reports from its investor day. Management unveiled ambitious long-term organic EBITDA growth targets of 15% to 20% annually through 2028, alongside AI-driven efficiency plans for its home and community-based care platform. The narrative projects $16.8 billion in revenue and $361.8 million in earnings by 2028, requiring 10.1% yearly revenue growth. Investors remain focused on whether BrightSpring can balance acquisition-driven expansion and technology investment whilst managing its substantial debt load and regulatory exposure.

Yahoo Finance
Mar 30th, 2026
BrightSpring Health Services stock surges 43% in 6 months, but low ROIC raises concerns

BrightSpring Health Services has seen its stock price surge 43.1% over the past six months to $42.32 per share, driven by strong quarterly results. The healthcare services company, founded in 1974, offers home health care, hospice, neuro-rehabilitation and pharmacy services. BrightSpring's revenue grew at an 18.3% compound annual growth rate over the past five years, outpacing the healthcare sector average. Analysts forecast 15% revenue growth over the next 12 months, though this represents a deceleration from its recent 20.9% annual rate. However, the company's five-year average return on invested capital of 4.9% falls below the typical cost of capital for healthcare firms, suggesting historically mediocre capital efficiency. The stock currently trades at 27.7× forward price-to-earnings ratio.

Yahoo Finance
Mar 25th, 2026
BrightSpring trades at 24.5x forward P/E despite $600M revenue headwinds

BrightSpring Health Services has raised questions about its valuation after trading at 24.5 times forward earnings following strong 2025 performance. The company reported fourth-quarter revenue of $3.55 billion, up 29.3% year-over-year, with adjusted EBITDA rising 40.7% to $184 million. For 2026, management guided revenue between $14.45 billion and $15 billion, representing 11.9% to 16.2% growth, whilst adjusted EBITDA is expected to grow faster at 23% to 28%, indicating margin expansion. However, the company faces approximately $600 million in revenue headwinds from Inflation Reduction Act impacts and brand-to-generic conversions. The valuation hinges on whether BrightSpring can deliver sequential profitability improvements throughout the year despite policy and product-mix pressures affecting headline revenue growth.

Yahoo Finance
Mar 24th, 2026
BrightSpring tops Q4 senior health earnings as Chemed's $639M revenue disappoints

BrightSpring Health Services led senior health stocks in Q4 earnings, reporting revenues of $3.55 billion, up 16.3% year on year and beating analyst expectations by 5%. The company delivered strong full-year EBITDA guidance. In contrast, Chemed posted the weakest performance, with revenues of $639.3 million falling 3% short of expectations. The company missed both revenue and full-year EPS guidance estimates, sending shares down 19.2% to $377.07. The seven senior health, home health and hospice stocks tracked reported slower Q4 results overall, with revenues beating consensus estimates by just 1.1%. Share prices have declined an average of 9.6% since earnings releases. The sector faces headwinds from labour shortages and wage inflation whilst benefiting from an ageing population and growing preference for in-home care.

Yahoo Finance
Mar 19th, 2026
BrightSpring projects sub-2x leverage in 2026, unveils $2B M&A firepower and integrated care strategy

BrightSpring Health Services outlined its growth strategy at an investor day, highlighting a shift towards core home-and-community clinical services. The company's planned community-living divestiture will close soon to boost cash flow and support integrated care initiatives. BrightSpring reported significant deleveraging from approximately 4.5x post-IPO to 2.99x (2.6x pro forma), with leverage expected to fall below 2x in 2026. The company reiterated 2026 guidance of $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA, whilst targeting 15–20% organic adjusted EBITDA compound annual growth for 2026–2028. The healthcare services provider has at least $2 billion available for acquisitions through 2028. Its operations include dispensing over 40 million prescriptions annually through PharMerica, serving more than 4 million patients, with recent branch integrations expected to add approximately $30 million of EBITDA.